An observational study in Azoospermia, Nonobstructive, sponsored by Assiut University. Status unknown. Open to male participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2020-12-21.
Sponsored by Assiut University · Observational
Measurement of clusterin level in the semen of infertile males undergoing testicular sperm extraction.
Clusterin, known as apolipoprotein J, sulphated glycoprotein-2 or testosterone - repressed prostate message-2.
It plays important roles in several pathophysiological processes, including tissue remodelling, lipid transport, reproduction, complement regulation and apoptotic cell death .
As clusterin expression is markedly upregulated in various normal and malignant tissues undergoing apoptosis, it has been regarded as a marker for cell death.
There is a conflicting findings concerning the relationship between elevated clusterin expression and enhanced induction of apoptosis; that is, clusterin has appeared to have a powerful anti-apoptotic function through a chaperone-like activity.
In addition to the anti-apoptotic activity, seminal clusterin was reported to promote a tolerogenic response to male antigens, thereby contributing to female tolerance to seminal antigens.
In the testis, clusterin is secreted by Sertoli cells into the fluid of the seminiferous epithelium and deposited onto the membranes of elongating spermatids and mature spermatozoa.
To date, however, there has been little information with respect to the functional roles of clusterin in the male reproductive tract under physiological conditions.
In particular, it remains controversial as to whether or not clusterin helps assist the normal spermatogenesis.
Nonobstructive azoospermia (NOA) males are characterised by impaired spermatogenesis.
Although NOA patients have impaired global spermatogenic function, focal areas of spermatogenesis may still exist in their testes.
Focal spermatogenesis could possibly be obtained by testicular sperm extraction (TESE) technique .
A number of factors have been suggested to be of predictive value for patients with a good chance to retrieve sperm cell such as testicular volume, serum FSH levels , serum total testosterone and serum inhibin B levels.
23 studies on the registry are indexed under Azoospermia, Nonobstructive; 7 are open to participants now.
This study's planned enrollment of 88 is close to the median of 94 across 10 observational studies indexed under Azoospermia, Nonobstructive.
Browse Azoospermia, Nonobstructive studies →Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Infertile Male patients (20 - 50 years ) with azoospermia undergoing testicular sperm extraction
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
• seminal sample for measuring clusterin level.
The level of seminal clusterin before testicular sperm Extraction.
Measurement of seminal clusterin by enzyme-linked immunosorbent assay (ELISA) and correlate them with the outcome of testicular sperm extraction to recognize predictors for spermatogenesis before testicular sperm extraction.
Time frame: 1 hour
No study locations are listed for this record.
This study is status unknown, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.